Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Multiple Doses of Intravenous Puricase in Subjects With Hyperuricemia and Refractory Gout

NCT00080210 is registered in ClinicalTrials.gov with Savient Pharmaceuticals as lead sponsor.

NCT NCT00080210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00080210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Multiple Doses of Intravenous Puricase in Subjects With Hyperuricemia and Refractory Gout
Lead sponsor
Savient Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2004
Completion date
February 28, 2005
Enrollment
40
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

gout